Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIC - Statin Termination in Cancer
NCT07543432Recruiting
- Sponsor
- Stockholms Sjukhem
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label trial in cardiovascular disease (CVD) (2 arms), sponsored by Stockholms Sjukhem. Primary endpoint: Low-Density Lipoprotein levels at 12 weeks. Started Sep 2025; status: recruiting.
02
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT07543432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07543432.